Corporate Statement

Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Overview

News Releases

27 Apr '22
Company Expects to Complete Irish Examinership and Emerge from Chapter 11 in the Next Few Weeks DUBLIN , April 27, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ) ("Mallinckrodt" or the "Company") today announced that the High Court of Ireland (the " Irish High Court ") has made an Order
28 Mar '22
– Electronic medical chart analysis showed Acthar Gel was associated with clinical improvements and a reduction in prescriptions for concomitant medications in refractory rheumatoid arthritis patients – DUBLIN , March 28, 2022 /PRNewswire/ --   Mallinckrodt plc , (OTCMKTS: MNKKQ) a global

Recent Events

Featured Reports

go back to the top of the page